External Lumbar Drainage to Abort Severe Traumatic IntraCranial Hypertension: A Phase 1 Randomized, Allocation-concealed, Open-label, Safety and Feasibility Clinical Trial

Status: Recruiting
Location: See all (5) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this phase 1 randomized controlled safety and feasibility clinical trial are to determine the safety of external lumbar drainage (ELD) in select patients with severe Traumatic Brain Injury (TBI). The main questions it aims to answer are (i) if ELD is feasible and (ii) safe to perform in severe TBI patients who have radiological evidence of patent basal cisterns and midline shift \<5mm without increasing the risk of neurological worsening or cerebral herniation. All participants will receive routine usual care. The study group will additionally have ELD for cerebrospinal fluid (CSF) drainage. A comparison will be made between the usual treatment plus ELD (interventional) groups, and the usual treatment (control) groups on incidence rate of neurological worsening or cerebral herniation events, and whether total hours with raised intracranial pressure (ICP) are different.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• 18-65 years age

• Glasgow Coma Scale (GCS) 3-8

• Pupils symmetric and bilaterally reactive

• Midline shift ≤5mm at the level of foramen of Monro on admission or post-operative brain CT

• Patent (complete or partial) quadrigeminal cisterns on admission or post-operative brain CT

• First randomization and intervention may be commenced within 24 hours of injury

• ELD safety score ≥5

Locations
United States
Florida
University of Florida
NOT_YET_RECRUITING
Gainesville
Kansas
Kansas University Medical Center
RECRUITING
Kansas City
Texas
University of Texas Southwestern Medical Center
NOT_YET_RECRUITING
Dallas
Brooke Army Medical Center
NOT_YET_RECRUITING
Fort Sam Houston
University of Texas
NOT_YET_RECRUITING
San Antonio
Contact Information
Primary
Carlos Morales, MPH
carlos.morales.ctr@usuhs.edu
240-6536638
Backup
Halinder S Mangat, MD, MSc
elastic@braintrauma.org
913-5886970
Time Frame
Start Date: 2024-06-24
Estimated Completion Date: 2027-06-30
Participants
Target number of participants: 30
Treatments
Experimental: 1st stage - prophylactic
External lumbar drainage @15mmHg if intracranial pressure is not raised on admission
Experimental: 2nd stage - treatment
External lumbar drainage @20mmHg if / when intracranial pressure \>20mmHg and tier 1 therapies cannot achieve ICP\<20mmHg
No_intervention: Usual treatment
Usual treatment as per SIBICC algorithm
Sponsors
Collaborators: Weill Medical College of Cornell University, The Cleveland Clinic, Uniformed Services University of the Health Sciences, University of Kansas
Leads: Brain Trauma Foundation

This content was sourced from clinicaltrials.gov